Luis M. Vilá to Antirheumatic Agents
This is a "connection" page, showing publications Luis M. Vilá has written about Antirheumatic Agents.
Connection Strength
2.663
-
Medina-Cintr?n N, Mart?nez I, P?rez-R?os N, Berr?os-L?pez Y, Vil? LM. Clinical Manifestations and Outcomes in Disease-Modifying Antirheumatic Drug-Naive Adult Patients with Chronic Chikungunya Arthritis. Am J Trop Med Hyg. 2021 03 08; 104(5):1741-1746.
Score: 0.764
-
V?zquez-Otero I, Medina-Cintr?n N, Arroyo-?vila M, Gonz?lez-Sep?lveda L, Vil? LM. Clinical impact of hydroxychloroquine dose adjustment according to the American Academy of Ophthalmology guidelines in systemic lupus erythematosus. Lupus Sci Med. 2020 05; 7(1).
Score: 0.720
-
Amaral JK, Bingham CO, Taylor PC, Vil? LM, Weinblatt ME, Schoen RT. Therapy for Chikungunya Arthritis: A Study of 133 Brazilian Patients. Am J Trop Med Hyg. 2023 09 06; 109(3):542-547.
Score: 0.226
-
Jolly M, Sehgal V, Arora S, Azizoddin D, Pinto B, Sharma A, Devilliers H, Inoue M, Toloza S, Bertoli A, Blazevic I, Vil? LM, Moldovan I, Torralba KD, Mazzoni D, Cicognani E, Hasni S, Goker B, Haznedaroglu S, Bourre-Tessier J, Navarra SV, Clarke A, Weisman M, Wallace D, Mok CC. Does hydroxychloroquine improve patient reported outcomes in patients with lupus? Lupus. 2021 Oct; 30(11):1790-1798.
Score: 0.196
-
Arroyo-?vila M, Vil? LM. Cardiac tamponade in a patient with mixed connective tissue disease. J Clin Rheumatol. 2015 Jan; 21(1):42-5.
Score: 0.124
-
Arroyo-?vila M, Vil? LM. Limited systemic sclerosis initially presenting with mesenteric panniculitis. BMJ Case Rep. 2014 Oct 17; 2014.
Score: 0.123
-
Willis R, Seif AM, McGwin G, Martinez-Martinez LA, Gonz?lez EB, Dang N, Papalardo E, Liu J, Vil? LM, Reveille JD, Alarc?n GS, Pierangeli SS. Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort. Lupus. 2012 Jul; 21(8):830-5.
Score: 0.102
-
Pons-Estel GJ, Alarc?n GS, Gonz?lez LA, Zhang J, Vil? LM, Reveille JD, McGwin G. Possible protective effect of hydroxychloroquine on delaying the occurrence of integument damage in lupus: LXXI, data from a multiethnic cohort. Arthritis Care Res (Hoboken). 2010 Mar; 62(3):393-400.
Score: 0.089
-
Santiago-Casas Y, Gonz?lez-Rivera TC, Castro-Santana LE, R?os G, Mart?nez D, Rodr?guez VE, Gonz?lez-Alcover R, Mayor AM, Vil? LM. Impact of age on clinical manifestations and outcome in Puerto Ricans with rheumatoid arthritis. Ethn Dis. 2010; 20(1 Suppl 1):S1-191-5.
Score: 0.088
-
Pons-Estel GJ, Alarc?n GS, McGwin G, Danila MI, Zhang J, Bastian HM, Reveille JD, Vil? LM. Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort. Arthritis Rheum. 2009 Jun 15; 61(6):830-9.
Score: 0.085
-
Vil? LM, Molina MJ. Chronic anemia and thrombocytosis as the initial presentation of Still's disease in an elderly patient. Gerontology. 2007; 53(5):289-92.
Score: 0.073
-
Alarc?n GS, McGwin G, Bertoli AM, Fessler BJ, Calvo-Al?n J, Bastian HM, Vil? LM, Reveille JD. Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L). Ann Rheum Dis. 2007 Sep; 66(9):1168-72.
Score: 0.073